BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:41 PM
 | 
Aug 10, 2007
 |  BC Extra  |  Company News

Bifeprunox not approvable

Wyeth (WYE) and Solvay (Euronext:SOLB) received a not approvable letter from FDA for an NDA for bifeprunox for the acute treatment and maintenance of schizophrenia. According to the companies, FDA said that in...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >